AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB

Durham, N.C., April 01, 2026 (GLOBE NEWSWIRE) — Final participant randomized in the GenePHIT Phase 2 clinical trial assessing safety and efficacy of AB-1002 for adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms Initial results are expected in the first half of 2027 Completion of enrollment marks significant... The post AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure appeared first on Montreal Gazette.


40 h.
Education
ID: 4955608382057930860


Similar News expand_more


Education
Education
Technology
Technology
Science
Education
Science
Technology
Education
Education
Science
Science
Education
Technology
Technology
Education
Science
Technology
Science
Technology
Science
Science
Economics
Science
Technology
Technology
Technology
Technology
Economics
Technology
Technology
Space
Science
Technology
Technology
Science
Economics
Technology
Economics
Science
Technology
Education
Technology
Technology
Technology
Economics
Culture
Sport
Education
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down